More news
Shares of Moderna Inc. MRNA sank 0.96% to $115.95 Wednesday, on what proved to be an all-around mixed trading session for the stock market, with the NASDAQ Composite Index COMP rising 0.88% to 18,188.
The U.S. government has awarded $176 million to Moderna for the development of its bird flu vaccine as the country faces a H5N1 virus outbreak in dairy cows.
Bird flu is not a big threat to people, despite outbreaks in poultry and cattle. But experts want a working vaccine that could be quickly rolled out, just in case the virus mutates and becomes a problem.
Shares of Moderna Inc. MRNA inched 0.97% higher to $117.07 Tuesday, on what proved to be an all-around great trading session for the stock market, with the NASDAQ Composite Index COMP rising 0.84% to 18,
The Department of Health and Human Services announced on Tuesday that Moderna will be given $176 million for its mRNA bird flu vaccine as part of the Biden administration’s preparedness efforts in the event of a widespread outbreak of the infection among humans.
The U.S. government has awarded vaccine maker Moderna a $176 million federal contract to help create a vaccine against pandemic influenza for people as concerns rise about a bird flu outbreak in cattle on U.
Scientists have long worried about the potential pandemic threat posed by the virus. Three humans in the U.S. have been infected during the current outbreak.
As fears of a pandemic mount, the biotech company’s mRNA vaccine trial is set to release Phase 1/2 results later this year, with a larger Phase 3 trial expected to begin in 2025 to combat bird flu.
Federal health officials have commissioned Moderna to develop a vaccine to protect people from an avian influenza that has been circulating in dairy cattle in recent months. U.S. Department of Health and Human Services officials said Tuesday the agency would devote about $176 million to the effort,
The US government will pay Moderna $176 million to develop an mRNA vaccine against a pandemic influenza—an award given as the highly pathogenic bird flu virus H5N1 continues to spread widely among US dairy cattle.
Moderna has a bird flu vaccine in early-stage testing that uses the same mRNA technology that allowed rapid development of COVID-19 vaccines
Moderna is already in the early stages of testing its new mRNA vaccine, meaning that it will be receiving supplementary funds for that research from the U.S. Department of Health and Human Services (HHS).
Moderna will receive $176 million to develop a pandemic flu vaccine for humans following a concerning outbreak of bird flu in dairy cows across the country, federal officials announced Tuesday. “We have successfully taken lessons learned during the COVID-19 pandemic and used them to better prepare for future public health crises,
On Tuesday, federal officials announced the U.S. will pay Moderna $176 million to develop a pandemic vaccine that could be used to treat bird flu.
Dr. Shira Doron, the Chief Infection Control Officer for Tufts Medicine health system, explains why the government would want to invest millions in development of a bird flu vaccine for humans.
Moderna Inc. secured nearly $200 million from the U.S. government to speed development of an mRNA vaccine for pandemic influenza as a dangerous strain of bird flu sweeps through the nation’s dairy farms,
An avian influenza virus has been spreading among dairy cows this spring and infected 3 people. The CDC says the public's risk for infection remains low.
The news comes as concern grows about cases of bird flu in dairy cows across the country, federal officials announced Tuesday.
Iowa dairy producers who’ve been impacted by bird flu can now apply for federal emergency funding. The USDA expanded its Emergency Assistance for Livestock, Honeybees, and Farm Raised Fish Program to help cover lost profits from the virus.
The U.S. government will pay the vaccine maker Moderna $176 million to accelerate development of a pandemic influenza vaccine that could be used to treat bird flu in people, as concern grows about cases in dairy cows across the country,
The U.S. government is helping fund Moderna's late-stage trials for its mRNA-based pandemic influenza vaccines as bird flu spreads in the U.S.
The U.S. Department of Health and Human Services said Tuesday it is funding the development of a vaccine based on the same mRNA technology that allowed the rapid development and rollout of vaccines to protect against COVID-19.
The U.S. government is paying Moderna $176 million to develop the vaccine as cases of bird flu in dairy cows continue to mount across the country.
The HHS's $176 million award to Moderna to expand their capabilities in developing mRNA-based pandemic influenza vaccines.